158 related articles for article (PubMed ID: 32492288)
1. Enantiomerically Pure Quinoline-Based κ-Opioid Receptor Agonists: Chemoenzymatic Synthesis and Pharmacological Evaluation.
Martin B; Schepmann D; Bernal FA; Schmidt TJ; Che T; Loser K; Wünsch B
ChemMedChem; 2020 Aug; 15(15):1408-1420. PubMed ID: 32492288
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Pharmacological Evaluation of Fluorinated Quinoxaline-Based κ-Opioid Receptor (KOR) Agonists Designed for PET Studies.
Tangherlini G; Börgel F; Schepmann D; Slocum S; Che T; Wagner S; Schwegmann K; Hermann S; Mykicki N; Loser K; Wünsch B
ChemMedChem; 2020 Oct; 15(19):1834-1853. PubMed ID: 33448685
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological evaluation of enantiomerically pure
Jonas H; Aiello D; Frehland B; Lehmkuhl K; Schepmann D; Köhler J; Diana P; Wünsch B
Org Biomol Chem; 2021 Oct; 19(38):8384-8396. PubMed ID: 34528988
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
[TBL] [Abstract][Full Text] [Related]
5. Lipase-catalyzed kinetic resolution as key step in the synthesis of enantiomerically pure σ ligands with 2-benzopyran structure.
Knappmann I; Lehmkuhl K; Köhler J; Schepmann D; Giera M; Bracher F; Wünsch B
Bioorg Med Chem; 2017 Jul; 25(13):3384-3395. PubMed ID: 28501431
[TBL] [Abstract][Full Text] [Related]
6. Design and Synthesis of Enantiomerically Pure Decahydroquinoxalines as Potent and Selective κ-Opioid Receptor Agonists with Anti-Inflammatory Activity in Vivo.
Soeberdt M; Molenveld P; Storcken RP; Bouzanne des Mazery R; Sterk GJ; Autar R; Bolster MG; Wagner C; Aerts SN; van Holst FR; Wegert A; Tangherlini G; Frehland B; Schepmann D; Metze D; Lotts T; Knie U; Lin KY; Huang TY; Lai CC; Ständer S; Wünsch B; Abels C
J Med Chem; 2017 Mar; 60(6):2526-2551. PubMed ID: 28218838
[TBL] [Abstract][Full Text] [Related]
7. Conformationally restricted κ-opioid receptor agonists: Synthesis and pharmacological evaluation of diastereoisomeric and enantiomeric decahydroquinoxalines.
Molenveld P; Bouzanne des Mazery R; Sterk GJ; Storcken RP; Autar R; van Oss B; van der Haas RN; Fröhlich R; Schepmann D; Wünsch B; Soeberdt M
Bioorg Med Chem Lett; 2015 Nov; 25(22):5326-30. PubMed ID: 26411794
[TBL] [Abstract][Full Text] [Related]
8. Methylated analogues of methyl (R)-4-(3,4-dichlorophenylacetyl)- 3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate (GR-89,696) as highly potent kappa-receptor agonists: stereoselective synthesis, opioid-receptor affinity, receptor selectivity, and functional studies.
Soukara S; Maier CA; Predoiu U; Ehret A; Jackisch R; Wünsch B
J Med Chem; 2001 Aug; 44(17):2814-26. PubMed ID: 11495592
[TBL] [Abstract][Full Text] [Related]
9. Conformationally constrained kappa receptor agonists: stereoselective synthesis and pharmacological evaluation of 6,8-diazabicyclo[3.2.2]nonane derivatives.
Geiger C; Zelenka C; Lehmkuhl K; Schepmann D; Englberger W; Wünsch B
J Med Chem; 2010 May; 53(10):4212-22. PubMed ID: 20441176
[TBL] [Abstract][Full Text] [Related]
10. Molecular Interaction Between Butorphanol and κ-Opioid Receptor.
Ji J; Lin W; Vrudhula A; Xi J; Yeliseev A; Grothusen JR; Bu W; Liu R
Anesth Analg; 2020 Sep; 131(3):935-942. PubMed ID: 32701545
[TBL] [Abstract][Full Text] [Related]
11. Chemoenzymatic Synthesis of Optically Active Ethereal Analog of
Borowiecki P
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233106
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 8-aminomorphans with high KOR affinity.
Jonas H; Aiello D; Schepmann D; Diana P; Wünsch B
Eur J Med Chem; 2022 Feb; 230():114079. PubMed ID: 35033825
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective synthesis and structure-affinity relationships of bicyclic kappa receptor agonists.
Kracht D; Rack E; Schepmann D; Fröhlich R; Wünsch B
Org Biomol Chem; 2010 Jan; 8(1):212-25. PubMed ID: 20024152
[TBL] [Abstract][Full Text] [Related]
14. N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy.
Béguin C; Potter DN; Dinieri JA; Munro TA; Richards MR; Paine TA; Berry L; Zhao Z; Roth BL; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM
J Pharmacol Exp Ther; 2008 Jan; 324(1):188-95. PubMed ID: 17951511
[TBL] [Abstract][Full Text] [Related]
15. Combination of cyclohexane and piperazine based κ-opioid receptor agonists: Synthesis and pharmacological evaluation of trans,trans-configured perhydroquinoxalines.
Bourgeois C; Werfel E; Schepmann D; Wünsch B
Bioorg Med Chem; 2014 Jul; 22(13):3316-24. PubMed ID: 24856182
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 7,9-diazabicyclo[4.2.2]decanes as conformationally restricted κ receptor agonists: fine tuning of the dihedral angle of the ethylenediamine pharmacophore.
Sunnam SK; Rack E; Schepmann D; Wünsch B
Eur J Med Chem; 2011 Jun; 46(6):1972-82. PubMed ID: 21481987
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization.
McLaughlin JP; Xu M; Mackie K; Chavkin C
J Biol Chem; 2003 Sep; 278(36):34631-40. PubMed ID: 12815037
[TBL] [Abstract][Full Text] [Related]
19. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
Schattauer SS; Kuhar JR; Song A; Chavkin C
Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
